Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...
Researchers sought to assess whether methylphenidate improves sleep disturbances in children with ADHD and whether dysregulation profile can affect this improvement.
Cingulate (CING) released Phase 3 safety data for its lead asset CTx-1301 for the treatment of Attention Deficit Hyperactivity Disorder, ADHD.
Dr Ray O’Connor takes a look at some of the most recent clinical studies on Attention-deficit hyperactivity disorder (ADHD) ...
The following is a summary of "Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism ...
Results Have Been Submitted Ahead of In-Person Meeting with FDA Set for April 2CTx-1301 is the First, True, Once-Daily Stimulant Medication to ...
Ruth Danoff was 50 when she was diagnosed with Attention-Deficit/ Hyperactivity Disorder or ADHD. At 63, she can look back ...
Charlie Health explores how groups can help people navigate ADHD symptoms, build coping strategies, and foster a sense of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback